Correlation analysis of plasma lipid profiles and the prognosis of head and neck squamous cell carcinoma

Oral Dis. 2024 Mar;30(2):329-341. doi: 10.1111/odi.14456. Epub 2022 Dec 15.

Abstract

Purpose: This study aims to clarify whether blood lipid profiles are indicators of prognosis in patients with head and neck squamous cell carcinoma (HNSCC).

Methods: This retrospective study included 512 T1/2N0M0 HNSCC patients. The correlation between blood lipid profiles and progression-free survival (PFS) and disease-specific survival (DSS) was analyzed by multivariate analysis. The data from TCGA was also analyzed to investigate the expression levels and prognostic values of different lipoprotein receptors essential for specific lipid uptake.

Results: A high level of low-density lipoprotein cholesterol (LDL-C) indicated better PFS and DSS, and a low level of apolipoprotein A-I (Apo A-I) indicated better PFS, while a high level of apolipoprotein B (Apo B) indicated poorer PFS and DSS. The Apo A-I receptor gene SCARB1 was upregulated and associated with poor survival in HNSCC patients. Activation of SCARB1 was implicated in a series of tumor-promoting pathways. There was no significant correlation between the expression of LDL-C and Apo B-related receptors and prognosis.

Conclusion: A high level of LDL-C and a low level of Apo A-I are protective factors for HNSCC, while a high level of Apo B is a risk factor. The upregulation of SCARB1 may participate in the progression of HNSCC.

Keywords: HNSCC; SCARB1; lipoprotein; prognosis.

MeSH terms

  • Apolipoprotein A-I*
  • Apolipoproteins B
  • Cholesterol, LDL
  • Head and Neck Neoplasms* / genetics
  • Humans
  • Lipids
  • Prognosis
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck

Substances

  • Apolipoprotein A-I
  • Cholesterol, LDL
  • Lipids
  • Apolipoproteins B